Editas Medicine (EDIT) Cash from Investing Activities (QoQ) (2015 - 2025)
Editas Medicine (EDIT) Cash from Investing Activities (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Editas Medicine | 242.79 Mn | 96.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7.21% |
| Jun 30, 2025 | -24.36% |
| Mar 31, 2025 | 82.14% |
| Dec 31, 2024 | -63.14% |
| Sep 30, 2024 | 61.64% |
| Jun 30, 2024 | 1,194.92% |
| Mar 31, 2024 | -107.55% |
| Dec 31, 2023 | 161.12% |
| Sep 30, 2023 | -892.02% |
| Jun 30, 2023 | -44.20% |
| Mar 31, 2023 | 184.52% |
| Dec 31, 2022 | -130.85% |
| Sep 30, 2022 | 2,329.56% |
| Jun 30, 2022 | -107.10% |
| Mar 31, 2022 | 346.81% |
| Dec 31, 2021 | 42.41% |
| Sep 30, 2021 | -927.82% |
| Jun 30, 2021 | 47.69% |
| Mar 31, 2021 | 102.98% |
| Dec 31, 2020 | 28.48% |